Radiation therapy of sinonasal natural killer/T-cell lymphoma

被引:2
|
作者
Riet, F. -G. [1 ]
Canova, C. -H. [1 ]
Gabarre, J. [2 ]
Ben Hassine, S. [1 ]
Kom, L. Kamsu [1 ]
Mazeron, J. -J. [1 ]
Feuvret, L. [1 ]
机构
[1] Grp Hosp Pitie Salpetriere, AP HP, Serv Oncol Radiotheapie, F-75651 Paris 13, France
[2] Grp Hosp Pitie Salpetriere, AP HP, Serv Hepatol, F-75651 Paris 13, France
来源
CANCER RADIOTHERAPIE | 2014年 / 18卷 / 02期
关键词
Natural killer (NK)/T-cell lymphoma; Nasal cavity; Radiation therapy; Chemotherapy; Combined chemoradiation; INTENSITY-MODULATED RADIOTHERAPY; WORLD-HEALTH-ORGANIZATION; INTERNATIONAL PROGNOSTIC INDEX; STAGE NASOPHARYNGEAL CARCINOMA; INVOLVED-FIELD RADIATION; ANGIOCENTRIC T-CELL; NASAL-TYPE; (NK)/T-CELL LYMPHOMA; SMILE CHEMOTHERAPY; SINGLE-CENTER;
D O I
10.1016/j.canrad.2013.11.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK)/T-cell lymphoma are part of lymphoproliferative diseases, they are rare in Europe and the United States but relatively common in Asia and South America. Natural killer (NK)/T-cell lymphoma present clinically as destructive lesions of the upper aerodigestive tract with perforation of deep structures of the face, destruction of the palate or an invasion of orbits. Treatment modalities of these lymphomas are still discussed because of the lack of available studies and the rarity of this disease. Radiotherapy provides a rapid control of the disease and is positioned as a major treatment of localized stages of NK/T-cell lymphoma of the nasal cavity. We therefore studied the different forms of radiation therapy in the early stages of nasal NK/T-cell lymphoma. (C) 2013 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [1] Extranodal natural killer/T-cell lymphoma: advances in the management
    Jaccard, Arnaud
    Hermine, Olivier
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) : 429 - 435
  • [2] Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management
    Tse, Eric
    Fox, Christopher P.
    Glover, Alexander
    Yoon, Sang Eun
    Kim, Won Seog
    Kwong, Yok-Lam
    SEMINARS IN HEMATOLOGY, 2022, 59 (04) : 198 - 209
  • [3] Practical management of natural killer/T-cell lymphoma
    Tse, Eric
    Kwong, Yok-Lam
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (05) : 480 - 486
  • [4] Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma
    Varelas, Antonios N.
    Ganti, Ashwin
    Eggerstedt, Michael
    Tajudeen, Bobby A.
    LARYNGOSCOPE, 2019, 129 (12) : 2675 - 2680
  • [5] Pathogenesis and Treatment of Extranodal Natural Killer/T-Cell Lymphoma
    Suzuki, Ritsuro
    SEMINARS IN HEMATOLOGY, 2014, 51 (01) : 42 - 51
  • [6] A novel prognostic model for extranodal natural killer/T-cell lymphoma
    Huang, Jia-Jia
    Zhu, Ying-Jie
    Xia, Yi
    Zhao, Wei
    Lin, Tong-Yu
    Jiang, Wen-Qi
    Huang, Hui-Qiang
    Li, Zhi-Ming
    MEDICAL ONCOLOGY, 2012, 29 (03) : 2183 - 2190
  • [7] Treatment modalities and overall survival outcomes for sinonasal extranodal natural killer/T-cell lymphoma
    Lehrich, Brandon M.
    Goshtasbi, Khodayar
    Abiri, Arash
    Yasaka, Tyler M.
    Papagiannopoulos, Peter
    Tajudeen, Bobby A.
    Brem, Elizabeth A.
    Kuan, Edward C.
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 727 - 730
  • [8] Review on natural killer/T-cell lymphoma
    He, Xiaohua
    Gao, Yan
    Li, Zhiming
    Huang, Huiqiang
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (02) : 221 - 229
  • [9] Extranodal Natural Killer/T-Cell Lymphoma in Children and Adolescents
    Huang, Yuhua
    Xie, Jianlan
    Ding, Yi
    Zhou, Xiaoge
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (01) : 46 - 54
  • [10] Risk stratification in extranodal natural killer/T-cell lymphoma
    Kohrt, Holbrook
    Lee, Mark
    Advani, Ranjana
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (09) : 1395 - 1405